Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 73

Daily Deal Round Up: September 20, 2022

DG Daiwa Ventures contributed to a $40m series B round for Yellow Card Financial while Vitol provided $37m in series C funding for VavaCars.

Sep 20, 2022

Is the US Inflation Reduction Act a "game changer" for clean energy…

Corporate investors have a new financial incentive to invest in renewables and climate technologies that often proved economically unviable in the past.

Sep 20, 2022

Daily Deal Round Up: September 19, 2022

Novo Holdings led a $75m series C round for Kate Farms while PayU and InfoEdge Ventures participated in DotPe’s $58m series B.

Sep 19, 2022

The Standout Six: Deals you need to note this week

Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.

Sep 16, 2022

Daily Deal Round Up: September 16, 2022

Intuitive Surgical was part of Galvanize Therapeutics’ $100m series B round while Intel Capital participated in a $90m series C for Fortanix.

Sep 16, 2022

What is strategic investing for a telecoms company in 2022?

As telecoms networks continue to expand their services, what even counts as a strategic investment these days? A selection of industry figures tell Global Venturing it can include Web3, ESG and 5G-related technologies.

Sep 16, 2022

Melnikova recruited to Pfizer Ventures

Pfizer Ventures has hired Irena Melnikova, formerly CFO of Umoja Biopharma and MD of SVB Leerink, as an executive director.

Sep 15, 2022

Daily Deal Round Up: September 15, 2022

Next47 has participated in a $205m series D round for Verkada while UPMC Enterprises has co-led SparingVision’s $75m series B.

Sep 15, 2022

How CVCs can survive a downturn — 6 tips from JetBlue and…

Invest in a business development function — early. Be creative with funding and careful with how your strategic value is measured.

Sep 15, 2022

Daily Deal Round Up: September 14, 2022

Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Sep 14, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here